What is the appropriate workup and treatment for a patient with microcytic hypochromic anemia and marked anisocytosis who has menorrhagia and is taking iron supplements?

Workup and Management of Microcytic Hypochromic Anemia with Marked Anisocytosis in a Patient with Menorrhagia on Iron Supplementation

In a premenopausal woman with menorrhagia already taking iron supplements who presents with persistent microcytic hypochromic anemia and marked anisocytosis, measure serum ferritin immediately to confirm inadequate iron repletion, assess response to current therapy, and determine whether oral iron is sufficient or intravenous iron is needed. 1

Diagnostic Workup Algorithm

Step 1: Confirm Iron Deficiency Status

• Measure serum ferritin as the single most specific test for iron deficiency 2, 1

  • Ferritin <15 μg/L is 99% specific for absolute iron deficiency 2, 1
  • Ferritin <45 μg/L provides optimal sensitivity-specificity balance (92% specificity) and warrants investigation 2, 1
  • Ferritin >150 μg/L essentially excludes absolute iron deficiency, even with inflammation 1

• If ferritin is 45-150 μg/L and inflammation is suspected, measure transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin to confirm functional iron deficiency 1

• Mean cell hemoglobin (MCH) is more reliable than MCV because it remains abnormal in both absolute and functional iron deficiency and is less affected by specimen storage 1

Step 2: Rule Out Alternative Causes of Microcytic Anemia

• Perform hemoglobin electrophoresis if iron studies are normal or equivocal to exclude thalassemia and hemoglobinopathies, particularly in patients of Mediterranean, African, Middle Eastern, or Southeast Asian descent 1

  • In thalassemia, MCV is disproportionately reduced relative to anemia severity 1

• Screen for celiac disease serologically, as it is found in 3-5% of IDA cases and impairs iron absorption 2

• Test for Helicobacter pylori, which can cause atrophic gastritis and impaired iron absorption 1, 3

Step 3: Assess for Occult Blood Loss Beyond Menorrhagia

Even in premenopausal women with menorrhagia, gastrointestinal investigation should be considered if:

• The patient has gastrointestinal symptoms 2

• There is a family history of GI pathology 2

• Anemia persists despite adequate iron replacement and menstrual management 2

• Perform urinalysis or urine microscopy to exclude urinary blood loss 2

• In men and postmenopausal women, gastroscopy and colonoscopy are mandatory first-line investigations regardless of anemia severity 2, 1

Step 4: Evaluate Current Iron Supplementation Adequacy

• Review the dose, formulation, and adherence to current iron therapy 1

  • Optimal oral iron dosing is 3-6 mg/kg elemental iron daily 4
  • Iron absorption is maximal on an empty stomach but can be taken with meals to improve tolerability 1
  • Co-administration with ~500 mg vitamin C enhances absorption 1

• A hemoglobin rise of ≥10 g/L within 2 weeks strongly confirms absolute iron deficiency and adequate response to therapy 1

• Review medications that impair iron absorption (proton pump inhibitors, H2 blockers, antacids) or cause GI bleeding (NSAIDs, anticoagulants) 1

Treatment Strategy

Oral Iron Optimization

• Continue or optimize oral ferrous salts (sulfate, fumarate, or gluconate) as first-line therapy unless contraindicated 1, 3

  • No single oral preparation has demonstrated superiority 1
  • Ensure adequate dosing: 3-6 mg/kg elemental iron daily 4

• Reassess hemoglobin and ferritin after 2-4 weeks to confirm response 1

Indications for Intravenous Iron

Switch to intravenous iron if: 1, 3

• Severe anemia is present (hemoglobin <7-8 g/dL)

• Poor tolerance or adherence to oral iron

• Malabsorption conditions (celiac disease, inflammatory bowel disease, atrophic gastritis)

• Inadequate response to oral therapy after 4-6 weeks

• Rapid iron repletion is necessary (e.g., before surgery)

• High-dose IV iron formulations are effective but require monitoring for hypersensitivity reactions, hypophosphatemia, and iron overload 3

Address Underlying Menorrhagia

• Coordinate with gynecology to manage menstrual blood loss through hormonal therapy, tranexamic acid, or procedural interventions 5

• Iron replacement alone may be insufficient if menstrual losses exceed absorptive capacity 5

Critical Pitfalls to Avoid

• Do not accept "normal" ferritin at face value if inflammation is present; ferritin is an acute-phase reactant and may be falsely elevated 2, 1

• Do not rely solely on MCV and MCH; their sensitivity declines in chronic disease, thalassemia, and mixed deficiencies 1

• Do not omit GI investigation in men or postmenopausal women, even with an obvious source like menorrhagia, because colorectal cancer can coexist 2, 1

• Do not pursue unnecessary GI workup if hemoglobin electrophoresis confirms thalassemia trait in patients with appropriate ethnic background and normal iron studies 1

• Do not overlook rare causes: iron-refractory iron deficiency anemia (IRIDA) due to TMPRSS6 mutations should be considered if there is complete resistance to oral iron and partial resistance to IV iron 3, 6

• Severe thrombocytopenia can rarely accompany profound iron deficiency anemia; platelet counts typically normalize with iron repletion 7